Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period.

Juliusson G, Hagberg O, Lazarevic VL, Ölander E, Antunovic P, Cammenga J, Wennström L, Möllgård L, Brune M, Jädersten M, Deneberg S, Lehmann S, Derolf ÅR, Höglund M.

Blood. 2019 Oct 31;134(18):1558-1561. doi: 10.1182/blood.2019001728. No abstract available.

PMID:
31515252
2.

Acute myeloid leukemia in very old patients.

Lazarevic VL, Bredberg A, Lorenz F, Öhlander E, Antunovic P, Cammenga J, Wennström L, Möllgård L, Deneberg S, Derolf Å, Höglund M, Juliusson G; Swedish AML Registry.

Haematologica. 2018 Dec;103(12):e578-e580. doi: 10.3324/haematol.2018.196691. Epub 2018 Jun 28. No abstract available.

3.

Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013.

Lehmann S, Deneberg S, Antunovic P, Rangert-Derolf Å, Garelius H, Lazarevic V, Myhr-Eriksson K, Möllgård L, Uggla B, Wahlin A, Wennström L, Höglund M, Juliusson G.

Leukemia. 2017 Jun;31(6):1457-1459. doi: 10.1038/leu.2017.71. Epub 2017 Feb 24. No abstract available.

PMID:
28232742
4.

Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population-based study from the Swedish AML registry.

Lazarevic VL, Rosso A, Juliusson G, Antunovic P, Derolf ÅR, Deneberg S, Möllgård L, Uggla B, Wennström L, Wahlin A, Höglund M, Lehmann S, Johansson B.

Eur J Haematol. 2017 May;98(5):493-500. doi: 10.1111/ejh.12861. Epub 2017 Mar 9.

PMID:
28152233
5.

An open-label phase I dose-finding study of APR-246 in hematological malignancies.

Deneberg S, Cherif H, Lazarevic V, Andersson PO, von Euler M, Juliusson G, Lehmann S.

Blood Cancer J. 2016 Jul 15;6(7):e447. doi: 10.1038/bcj.2016.60. No abstract available.

6.

Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes.

Qu Y, Lennartsson A, Gaidzik VI, Deneberg S, Karimi M, Bengtzén S, Höglund M, Bullinger L, Döhner K, Lehmann S.

Epigenetics. 2014 Aug;9(8):1108-19. doi: 10.4161/epi.29315. Epub 2014 May 27.

7.

microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia.

Deneberg S, Kanduri M, Ali D, Bengtzen S, Karimi M, Qu Y, Kimby E, Mansouri L, Rosenquist R, Lennartsson A, Lehmann S.

Epigenetics. 2014 Jun;9(6):910-7. doi: 10.4161/epi.28603. Epub 2014 Mar 31.

8.

A combination regimen of bortezomib, cyclophosphamide and betamethasone gives quicker, better and more durable response than VAD/CyBet regimens: results from a Swedish retrospective analysis.

Uttervall K, Admasie J, Alici E, Lund J, Liwing J, Aschan J, Barendse M, Deneberg S, Mellqvist UH, Carlson K, Nahi H.

Acta Haematol. 2013;130(1):7-15. doi: 10.1159/000345422. Epub 2013 Jan 25.

9.

Epigenetics in myeloid malignancies.

Deneberg S.

Methods Mol Biol. 2012;863:119-37. doi: 10.1007/978-1-61779-612-8_7. Review.

PMID:
22359290
10.

Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks.

Deneberg S, Guardiola P, Lennartsson A, Qu Y, Gaidzik V, Blanchet O, Karimi M, Bengtzén S, Nahi H, Uggla B, Tidefelt U, Höglund M, Paul C, Ekwall K, Döhner K, Lehmann S.

Blood. 2011 Nov 17;118(20):5573-82. doi: 10.1182/blood-2011-01-332353. Epub 2011 Sep 29.

PMID:
21960591
11.

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.

Lehmann S, Ravn A, Carlsson L, Antunovic P, Deneberg S, Möllgård L, Derolf AR, Stockelberg D, Tidefelt U, Wahlin A, Wennström L, Höglund M, Juliusson G.

Leukemia. 2011 Jul;25(7):1128-34. doi: 10.1038/leu.2011.78. Epub 2011 Apr 19.

PMID:
21502956
12.

APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells.

Ali D, Jönsson-Videsäter K, Deneberg S, Bengtzén S, Nahi H, Paul C, Lehmann S.

Eur J Haematol. 2011 Mar;86(3):206-15. doi: 10.1111/j.1600-0609.2010.01557.x. Epub 2011 Jan 11.

PMID:
21114538
13.

Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia.

Deneberg S, Grövdal M, Karimi M, Jansson M, Nahi H, Corbacioglu A, Gaidzik V, Döhner K, Paul C, Ekström TJ, Hellström-Lindberg E, Lehmann S.

Leukemia. 2010 May;24(5):932-41. doi: 10.1038/leu.2010.41. Epub 2010 Mar 18.

PMID:
20237504
14.

Single nucleotide polymorphism genomic arrays analysis of t(8;21) acute myeloid leukemia cells.

Akagi T, Shih LY, Ogawa S, Gerss J, Moore SR, Schreck R, Kawamata N, Liang DC, Sanada M, Nannya Y, Deneberg S, Zachariadis V, Nordgren A, Song JH, Dugas M, Lehmann S, Koeffler HP.

Haematologica. 2009 Sep;94(9):1301-6. doi: 10.3324/haematol.2009.005744.

15.

Low p14ARF expression in de novo acute myeloid leukemia with normal karyotype is associated with poor survival.

Paul E, Paul E, Uggla B, Deneberg S, Bengtzen S, Hermansson M, Dahlman I, Rosenquist R, Wiman KG, Nahi H.

Leuk Lymphoma. 2009 Sep;50(9):1512-8. doi: 10.1080/10428190903111914.

PMID:
19626541
16.

Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation.

Paul E, Sutlu T, Deneberg S, Alici E, Björkstrand B, Jansson M, Lerner R, Wallblom A, Gahrton G, Nahi H.

Oncol Rep. 2009 Jul;22(1):137-42.

PMID:
19513515
17.

The FLT3 inhibitor PKC412 in combination with cytostatic drugs in vitro in acute myeloid leukemia.

Möllgård L, Deneberg S, Nahi H, Bengtzen S, Jonsson-Videsäter K, Fioretos T, Andersson A, Paul C, Lehmann S.

Cancer Chemother Pharmacol. 2008 Aug;62(3):439-48. Epub 2007 Oct 25.

PMID:
17960382
18.

Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease: implications for its use?

Deneberg S, Lerner R, Ljungman P, Ringden O, Hägglund H.

Med Oncol. 2007;24(3):354-6.

PMID:
17873314
19.

Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study.

Hafström I, Rohani M, Deneberg S, Wörnert M, Jogestrand T, Frostegård J.

J Rheumatol. 2007 Sep;34(9):1810-6. Epub 2007 Aug 1.

PMID:
17696277

Supplemental Content

Loading ...
Support Center